YourBio Health, Inc. (formerly Seventh Sense Biosystems)
Profile date: 2026-06-16
Corporate Profile: YourBio Health, Inc.
Executive Summary
YourBio Health, Inc. (formerly operating as Seventh Sense Biosystems) is an American biomedical technology company specializing in the design, development, and manufacture of advanced, remote microsampling solutions. Originating as a Flagship Pioneering portfolio company incubated within its VentureLabs framework, the company is headquartered in Medford, Massachusetts. YourBio Health operates at the convergence of medical devices, decentralized clinical trial infrastructure, and digital telehealth delivery.
The core mission of YourBio Health is to eliminate the physical barriers, logistical constraints, and deep-seated patient anxieties associated with traditional venous blood draws. The entity achieves this by engineering push-button, virtually painless capillary blood collection devices that enable high-volume blood specimens to be self-collected by a layperson in any remote or domestic environment. Following critical FDA 510(k) clearances and European CE Marking, the company transitioned its primary business model toward specialized business-to-business (B2B) alignments, supporting contract research organizations (CROs), diagnostics providers, and biometric wellness firms. In early 2026, YourBio Health was acquired by the prominent digital healthcare platform Hims & Hers Health, Inc., folding its proprietary micro-needle architecture into a global telehealth ecosystem to modernize remote longitudinal patient testing.
Core Operations & Technological Infrastructure
YourBio Health focuses its core operations on solving the traditional limitations of capillary microsampling. Historical fingerstick lancet methods typically yield insufficient or heavily hemolyzed (damaged) blood volumes that are highly incompatible with multi-analyte automated laboratory diagnostic systems. YourBio Health's operational framework relies on a specialized bio-interface engine designed to bridge this gap.
1. Proprietary HALO? Technology Architecture
The fundamental technological differentiator behind YourBio Health?s operations is its patented HALO? microneedle array system. Rather than utilizing a singular heavy surgical steel blade or a deeply penetrating venipuncture needle, the HALO framework relies on an array of custom-engineered micro-needles that are thinner than a human eyelash.
* Depth Limitation: The array is mechanically restricted to pierce only approximately 1 millimeter into the skin surface.
* Nerve Avoidance: By maintaining this shallow depth profile, the micro-needles stay entirely above the deep dermis layer where pain-sensing nerve endings are heavily concentrated.
* Rapid Retraction: Upon mechanical activation, the needles penetrate and cleanly retract within a fraction of a millisecond, leaving the micro-perforations virtually unfelt by the patient.
2. Gentle Vacuum-Assisted Fluid Dynamics
Once the micro-needles pierce the stratum corneum and access the highly vascularized superficial capillary bed, the internal fluid engineering mechanics take over. The device initiates a localized, controlled vacuum micro-environment over the collection zone. This negative pressure actively and continuously draws a steady stream of whole, high-quality capillary blood out of the micro-vessels without structural shear stress, bypassing the need for manual squeezing or milking of the tissue, which routinely causes sample hemolysis and invalidates diagnostic parameters.
To operate effectively within the stringent data validation requirements of clinical trials, YourBio Health?s clinical team conducts continuous validation studies showing high venous concordance. This ensures that the whole capillary blood harvested via their upper-arm devices yields identical analytical chemical profiles to traditional blood draws pulled from a vein via an extensive needle syringe, rendering the samples fully compatible with conventional, high-throughput laboratory analyzers.
Comprehensive Product Offerings & Specifications
YourBio Health provisions a distinct family of medical devices known as Touch Activated Phlebotomy (TAP?) hardware, alongside customized logistical and processing support.
1. The TAP? Micro Select Device
The TAP? Micro Select represents the company's latest high-volume, advanced clinical microsampling product. It features FDA 510(k) clearance in the United States and official CE Mark certification across Europe.
* Design & Form Factor: Compact, lightweight, single-use enclosed plastic node weighing approximately 30 grams, engineered for straightforward, self-guided attachment to the patient's upper deltoid muscle via an integrated skin adhesive ring.
* Collection Output: Safely manages and collects up to 500 microliters ($\mu\text{L}$) to 900 microliters ($\mu\text{L}$) of high-quality, whole liquid capillary blood within a typical 5 to 10-minute window.
* Tube Compatibility: Engineered to interface modularly with various industry-standard micro-collection tubes and internal anticoagulants (such as EDTA or serum-separating gels), allowing labs to process the tubes directly through existing standard centrifuges and diagnostic equipment.
2. The TAP? II Device System
The TAP? II system is an established, internationally deployed microfluidic hardware variant customized for targeted decentralized diagnostics, clinical research, and remote screening applications.
* Activation Protocol: Utilizes a simple mechanical push-button interface that a patient or a minimal-training caregiver can deploy at home.
* Multi-Biomarker Capability: Validated to support blood collection for a massive array of diagnostic panels, including antibody serology, lipids, hormone panels, HbA1c (glycated hemoglobin), inflammatory biomarkers, genomics, and epigenetic screening applications.
To ensure its physical products flow seamlessly throughout the healthcare system, YourBio Health provides turnkey, end-to-end kit products.
* The At-Home Testing Kit Asset: A standardized, room-temperature stable shippable kit box incorporating the primary TAP? device, skin prep pads, site-warming packs (engineered to optimize local capillary microcirculation), secure sample transport containers built with robust thermal stability configurations, clear visual instructions for use, and pre-paid overnight courier return packaging.
B2B Commercial Applications & Industry Impact
YourBio Health commercializes its technological assets across three distinct high-value verticals within the broader life sciences industry:
1. Decentralized Clinical Trials (DCTs)
Contract Research Organizations (CROs) and pharmaceutical sponsors integrate TAP? hardware directly into clinical study designs to minimize patient drop-out rates. By allowing trial participants to perform routine pharmacokinetic and safety lab draws from their own homes, sponsors eliminate the friction of geographic clinic visits, radically broadening demographic recruitment diversity and enhancing overall compliance.
2. Telehealth & Direct-to-Consumer Screening
Following its acquisition by Hims & Hers Health, Inc., YourBio Health provides the core diagnostic backbone for remote healthcare management. Patients seeking specialized or preventive medical treatments can receive a TAP? kit in the mail, self-collect their blood sample without entering a brick-and-mortar clinic, and route the sample to a certified central laboratory to inform their remote clinical consultations.
3. Wellness and Longevity Platforms
The company partners with modern biometric and preventative wellness enterprises to provide convenient, recurring nutritional assessments, allergy profiles, and metabolic health tracking, redefining how consumers engage with their biological data.
Please note: This information is generated by AI. For legal use, verify with company sources.
